SCHEMBL1236714

SCHEMBL1236714

C=CCNS(=O)(=O)c1cc(-c2sc(NC(C)=O)nc2C)c(Br)s1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PIK3CG P48736 16/20 0.50
ALDH1A1 P00352 2/20 0.50
MAPT P10636 2/20 0.50
HTT P42858 2/20 0.50
HSD17B10 Q99714 2/20 0.50
KDM4E B2RXH2 1/20 0.50
HPGD P15428 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
PIK3CD O00329 12/20 0.49
PIK3C3 Q8NEB9 2/20 0.49
PIK3CA P42336 10/20 0.45
PIK3CB P42338 9/20 0.45
PI4KB Q9UBF8 3/20 0.43
PIK3C2A O00443 1/20 0.43
PIK3C2B O00750 1/20 0.43
PI4KA P42356 1/20 0.43
PRKDC P78527 1/20 0.43
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1235140 0.86 PIK3CG (0.54) PIK3CGPIK3CDPIK3C3PIK3CAPIK3CB
SCHEMBL1237820 0.86 PIK3CG (0.66) PIK3CGPIK3CDPIK3C3PIK3CAPIK3CB
SCHEMBL1236946 0.84 PIK3CG (0.59) PIK3CGPIK3CDPIK3C3PIK3CAPIK3CB
SCHEMBL1236756 0.83 PIK3CG (0.54) PIK3CGALDH1A1PIK3CDPIK3C3PIK3CA
SCHEMBL1236446 0.82 PIK3CG (0.50) PIK3CGPIK3CDPIK3C3PIK3CAPIK3CB
SCHEMBL1236497 0.81 PIK3CG (0.56) PIK3CGALDH1A1MAPTHTTHSD17B10
SCHEMBL1237698 0.81 PIK3CG (0.52) PIK3CGPIK3CDPIK3C3PIK3CAPIK3CB
SCHEMBL1235243 0.81 PIK3CG (0.53) PIK3CGALDH1A1MAPTHTTHSD17B10
SCHEMBL1235130 0.79 PIK3CG (0.49) PIK3CGALDH1A1MAPTPIK3CDPIK3C3
SCHEMBL1237462 0.78 PIK3CG (0.48) PIK3CGPIK3CDPIK3C3PIK3CAPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8399497-B2 Thiazole derivatives and use thereof MERCK SERONO SA (CH) 2013-03-19 US disclosed
EP-1885716-B1 THIAZOLE DERIVATIVES AND USE THEREOF MERCK SERONO SA (CH) 2012-11-07 EP disclosed
US-20110086843-A1 Thiazole Derivatives and Use Thereof MERCK SERONO SA (CH) 2011-04-14 US disclosed
US-7879888-B2 N-(4-methyl-5-{5-[(prop-2-yn-1-ylamino)sulfonyl]-2-thienyl}-1,3-thiazol-2-yl)acetamide; autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infections, kidney diseases, platelet aggregation, cancer, transplantation, graft rejection MERCK SERONO SA (CH) 2011-02-01 US disclosed
US-20080221180-A1 Thiazole Derivatives and Use Thereof LABORATORIES SERONO SA (CH) 2008-09-11 US disclosed
EP-1885716-A1 THIAZOLE DERIVATIVES AND USE THEREOF Laboratoires Serono SA (CH) 2008-02-13 EP disclosed
WO-2006125803-A1 THIAZOLE DERIVATIVES AND USE THEREOF LABORATOIRES SERONO S.A. (CH) 2006-11-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221180-A1 Thiazole Derivatives and Use Thereof PDGFRB, PDGFRA, TEC PIK3CG 2526/4885ALDH1A1 174/4885MAPT 1418/4885
US-20110086843-A1 Thiazole Derivatives and Use Thereof PDGFRB, PDGFRA, TEC PIK3CG 2526/4885ALDH1A1 174/4885MAPT 1418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.